Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Isoniazid Adjuvant Therapy For MDR-TB
NCT00513396Phase 3Completed
- Sponsor
- GSVM Medical College
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of isoniazid in Tuberculosis (TB), sponsored by GSVM Medical College. Started Jan 2004; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00513396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513396.